Back
Recursion Pharmaceuticals Stock Predictions
Buy
74
RXRX
Recursion Pharmaceuticals
Last Price:
9.42
Seasonality Move:
66.82%
7 Day Trial
ALL ACCESS PASS
$
7
Recursion Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 0.1% based on the past 3 years of stock performance.
- Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Recursion Pharmaceuticals Stock Undervalued?
The current Recursion Pharmaceuticals [RXRX] share price is $9.42. The Score for RXRX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. - RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 0.1% based on the past 3 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Buy
74
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals overpriced?
- Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
16.75
52-Week Low:
4.97
Prediction Charts
Market Cap:
2.24B
Price in USD:
9.42
Volume:
4.72M
Beta:
0.86
Technical Analysis
SMA50:
9.20
SMA100:
10.21
SMA200:
8.98
52-Wk Change:
75.09%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?
Yes, Recursion Pharmaceuticals is a publicly traded company. -
What is the Recursion Pharmaceuticals stock quote today?
The Recursion Pharmaceuticals stock price is 9.42 USD today. -
How to buy Recursion Pharmaceuticals stock online?
You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 8.06 | 7.81 | 8.26 | 7.80 |
| May-1 | 7.75 | 8.34 | 8.75 | 7.73 |
| May-2 | 8.47 | 8.79 | 8.79 | 8.30 |
| May-3 | 9.24 | 8.84 | 9.40 | 8.70 |
| May-6 | 8.93 | 8.94 | 9.21 | 8.82 |
| May-7 | 8.90 | 8.80 | 9.05 | 8.57 |
| May-8 | 8.56 | 8.59 | 8.77 | 8.43 |
| May-9 | 8.60 | 8.64 | 8.69 | 8.46 |
| May-10 | 9.05 | 8.60 | 9.34 | 8.22 |
| May-13 | 9.42 | 9.48 | 10.40 | 9.06 |
| May-14 | 9.73 | 10.05 | 10.56 | 9.70 |
| May-15 | 10.34 | 10.01 | 10.67 | 9.68 |
| May-16 | 10.05 | 9.51 | 10.11 | 9.43 |
| May-17 | 9.50 | 9.42 | 9.58 | 9.17 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.25 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.15 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.